How Recent Developments Are Shaping the Philip Morris International Investment Story

The consensus analyst price target for Philip Morris International has recently decreased from $188.00 to $185.44. This reflects some revised expectations after the company’s latest quarterly results. The change is informed by a blend of optimism over the firm's operational strengths and caution about its near-term guidance. Stay tuned to see how investors can monitor future shifts in the evolving Philip Morris International narrative.

Stay updated as the Fair Value for Philip Morris International shifts by adding it to your watchlist or portfolio. Alternatively, explore our Community to discover new perspectives on Philip Morris International.

What Wall Street Has Been Saying

🐂 Bullish Takeaways

Stifel analyst Matthew Smith sees the recent pullback in Philip Morris shares as an "attractive buying point," pointing to better-than-expected third-quarter organic sales, profit margin expansion, and EPS growth as indicators of the company’s strong execution. The selloff following the earnings report is viewed by Stifel as "an over-reaction," suggesting investors may be undervaluing the company’s ongoing operational strengths and growth momentum. Stifel maintains a Buy rating and cites continued confidence in Philip Morris International’s ability to deliver on strategic goals despite near-term volatility.

🐻 Bearish Takeaways

Some concerns persist regarding the company’s slightly reduced operating profit guidance and expectations for a weaker fourth quarter, as highlighted by Stifel. U.S. ZYN dynamics and tempered near-term outlook are viewed as headwinds that could affect the company’s immediate valuation and pace of earnings growth.

Do your thoughts align with the Bull or Bear Analysts? Perhaps you think there's more to the story. Head to the Simply Wall St Community to discover more perspectives or begin writing your own Narrative!NYSE:PM Community Fair Values as at Nov 2025

What's in the News

Philip Morris International has provided its full-year 2025 guidance, projecting diluted EPS between $7.39 and $7.49, organic net revenue growth of 6% to 8%, and organic operating income growth of 10% to 11.5%. This outlook includes increased investments in the U.S. market. The company recently presented evidence to the FDA’s Tobacco Products Scientific Advisory Committee as part of an ongoing review of its IQOS heated tobacco products for continued marketing as modified risk tobacco products in the U.S. PMI reports its smoke-free products are now available in 97 markets and used by over 41 million legal-age consumers globally. Philip Morris International announced a $37 million expansion of its manufacturing facility in Wilson, North Carolina, adding a new TEREA production line and preparing for a potential U.S. launch of IQOS ILUMA, contingent upon FDA approval. The board of directors approved an 8.9% increase in the quarterly dividend, raising it to an annualized rate of $5.88 per share effective October 2025.

Story Continues

How This Changes the Fair Value For Philip Morris International

Fair Value: The consensus analyst price target has decreased slightly from $188.00 to $185.44. Discount Rate: The discount rate has risen marginally from 7.72% to 7.80%. Revenue Growth: Projected revenue growth has declined moderately, moving from 8.03% to 7.69%. Net Profit Margin: The expected net profit margin has decreased from 29.22% to 28.62%. Future P/E: The expected future price-to-earnings ratio has increased slightly from 25.10x to 25.39x.

🔔 Never Miss an Update: Follow The Narrative

Narratives are a smarter way to invest, letting you see beyond the numbers by linking a company’s story to revenue forecasts, profit margins, and fair value. On Simply Wall St’s Community page, millions of investors create and follow Narratives. Real users share their perspectives, helping you decide when to buy or sell by comparing fair value to price. Narratives update as news breaks or earnings come in, keeping your decisions fresh and relevant.

Curious what the current story is for Philip Morris International? Read the full original Narrative here and discover why it’s worth following:

Learn how global adoption of smoke-free products, regulatory support, and digital innovation are fueling the company’s growth and margin expansion. Understand the key risks from regulatory changes, declining cigarette demand, and currency volatility that could impact future performance. See up-to-date analyst forecasts for revenue, profit margins, and the fair value relative to today’s price. All information is updated when new details emerge.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include PM.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email [email protected]

View Comments